Condensed Consolidated Statements of Stockholders' Equity - USD ($)	Total	Common Stock	Additional Paid In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020		4,258,105
Beginning balance at Dec. 31, 2020	$ 35,492,242	$ 4,259	$ 100,203,979	$ (64,689,065)	$ (26,931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		65,962
Exercise of stock options	579,619	$ 66	579,553
Restricted stock issued (in shares)		6,527
Restricted stock issued	0	$ 6	(6)
Stock based compensation	745,620		745,620
Net (loss) income	(2,844,230)			(2,844,230)
Other comprehensive loss - foreign currency translation adjustment	12,501				12,501
Ending balance (in shares) at Mar. 31, 2021		4,330,594
Ending balance at Mar. 31, 2021	33,985,752	$ 4,331	101,529,146	(67,533,295)	(14,430)
Beginning balance (in shares) at Dec. 31, 2020		4,258,105
Beginning balance at Dec. 31, 2020	35,492,242	$ 4,259	100,203,979	(64,689,065)	(26,931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Debt issuance cost associated with debt conversion	0
Net (loss) income	2,256,460
Other comprehensive loss - foreign currency translation adjustment	81
Ending balance (in shares) at Sep. 30, 2021		4,618,221
Ending balance at Sep. 30, 2021	42,005,357	$ 4,618	104,460,194	(62,432,605)	(26,850)
Beginning balance (in shares) at Mar. 31, 2021		4,330,594
Beginning balance at Mar. 31, 2021	33,985,752	$ 4,331	101,529,146	(67,533,295)	(14,430)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		5,630
Exercise of stock options	36,605	$ 6	36,599
Restricted stock issued (in shares)		13,375
Restricted stock issued	0	$ 13	(13)
Stock based compensation	654,562		654,562
Net (loss) income	1,683,591			1,683,591
Other comprehensive loss - foreign currency translation adjustment	(4,446)				(4,446)
Ending balance (in shares) at Jun. 30, 2021		4,349,599
Ending balance at Jun. 30, 2021	36,356,064	$ 4,350	102,220,294	(65,849,704)	(18,876)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		268,622
Exercise of stock options	1,545,834	$ 268	1,545,566
Stock based compensation	694,334		694,334
Net (loss) income	3,417,099			3,417,099
Other comprehensive loss - foreign currency translation adjustment	(7,974)				(7,974)
Ending balance (in shares) at Sep. 30, 2021		4,618,221
Ending balance at Sep. 30, 2021	$ 42,005,357	$ 4,618	104,460,194	(62,432,605)	(26,850)
Beginning balance (in shares) at Dec. 31, 2021	4,909,846	4,909,846
Beginning balance at Dec. 31, 2021	$ 46,839,808	$ 4,910	108,569,988	(61,680,275)	(54,815)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Return of profit	5,824		5,824
Exercise of stock options (in shares)		7,097
Exercise of stock options	91,634	$ 7	91,627
Restricted stock issued (in shares)		31,746
Restricted stock issued	0	$ 32	(32)
Stock issued from converted debt (in shares)		130,916
Stock issued from converted debt	2,571,200	$ 131	2,571,069
Debt issuance cost associated with debt conversion	(109,399)		(109,399)
Stock based compensation	2,079,159		2,079,159
Net (loss) income	(12,187,830)			(12,187,830)
Other comprehensive loss - foreign currency translation adjustment	(27,150)				(27,150)
Ending balance (in shares) at Mar. 31, 2022		5,079,605
Ending balance at Mar. 31, 2022	$ 39,263,246	$ 5,080	113,208,236	(73,868,105)	(81,965)
Beginning balance (in shares) at Dec. 31, 2021	4,909,846	4,909,846
Beginning balance at Dec. 31, 2021	$ 46,839,808	$ 4,910	108,569,988	(61,680,275)	(54,815)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued (in shares)		51,671
Performance stock units issued (in shares)		20,185
Issuance of common stock, net of issuance cost (in shares)		7,097
Debt issuance cost associated with debt conversion	(109,399)
Net (loss) income	(33,841,015)
Other comprehensive loss - foreign currency translation adjustment	$ (193,314)
Ending balance (in shares) at Sep. 30, 2022	5,164,951	5,164,951
Ending balance at Sep. 30, 2022	$ 20,501,989	$ 5,165	116,266,243	(95,521,290)	(248,129)
Beginning balance (in shares) at Mar. 31, 2022		5,079,605
Beginning balance at Mar. 31, 2022	39,263,246	$ 5,080	113,208,236	(73,868,105)	(81,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	0
Restricted stock issued (in shares)		15,375
Restricted stock issued	0	$ 15	(15)
Performance stock units issued (in shares)		20,185
Performance stock units issued	0	$ 20	(20)
Issuance of common stock, net of issuance cost (in shares)		7,410
Issuance of common stock, net of issuance cost	135,678	$ 6	135,672
Stock based compensation	2,095,118		2,095,118
Net (loss) income	(11,736,546)			(11,736,546)
Other comprehensive loss - foreign currency translation adjustment	(161,185)				(161,185)
Ending balance (in shares) at Jun. 30, 2022		5,122,575
Ending balance at Jun. 30, 2022	29,596,311	$ 5,121	115,438,991	(85,604,651)	(243,150)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued (in shares)		4,550
Restricted stock issued	0	$ 6	(6)
Issuance of common stock, net of issuance cost (in shares)		37,826
Issuance of common stock, net of issuance cost	402,615	$ 38	402,577
Stock based compensation	424,681		424,681
Net (loss) income	(9,916,639)			(9,916,639)
Other comprehensive loss - foreign currency translation adjustment	$ (4,979)				(4,979)
Ending balance (in shares) at Sep. 30, 2022	5,164,951	5,164,951
Ending balance at Sep. 30, 2022	$ 20,501,989	$ 5,165	$ 116,266,243	$ (95,521,290)	$ (248,129)